Rani Therapeutics Holdings, Inc. (RANI)
USD 1.33
(-8.9%)
USD 1.33
(-8.9%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | - | - | 2.71 Million | 462 Thousand | 979 Thousand |
| Cost of Revenue | 822 Thousand | 1.31 Million | - | - | - |
| Gross Profit | -822 Thousand | -1.31 Million | 2.71 Million | 462 Thousand | 979 Thousand |
| Operating Expenses | 66.09 Million | 63.45 Million | 54.31 Million | 17 Million | 28.04 Million |
| Selling, General and Administrative Expenses | 26.47 Million | 26.84 Million | 27.83 Million | 4.96 Million | 3.46 Million |
| Research and Development Expenses | 39.62 Million | 36.6 Million | 26.48 Million | 12.04 Million | 24.57 Million |
| Other Expenses | - | - | - | - | - |
| Cost and Expenses | 66.09 Million | 63.45 Million | 54.31 Million | 17 Million | 28.04 Million |
| Operating Income | -66.09 Million | -63.45 Million | -51.59 Million | -16.54 Million | -27.06 Million |
| Interest Expense | 5.08 Million | 1.07 Million | 466 Thousand | 124 Thousand | 10 Thousand |
| Income Tax Expense | - | 70 Thousand | 41 Thousand | 35 Thousand | 10 Thousand |
| Earnings before Tax | -67.88 Million | -63.27 Million | -53.04 Million | -16.66 Million | -26.58 Million |
| Net Income | -33.97 Million | -63.34 Million | -53.08 Million | -16.7 Million | -26.59 Million |
| Earnings Per Share Basic | -1.33 | -2.66 | -2.69 | -0.85 | -1.35 |
| Earnings Per Share Diluted | -1.33 | -2.66 | -2.69 | -0.85 | -1.35 |
| Weighted Average Shares Outstanding | 25.5 Million | 23.81 Million | 19.71 Million | 19.73 Million | 19.73 Million |
| Weighted Average Shares Outstanding (Diluted) | 25.5 Million | 23.81 Million | 19.71 Million | 19.73 Million | 19.73 Million |
| Gross Margin | - | - | 1.00 | 1.00 | 1.00 |
| EBIT Margin | - | - | -18.96 | -34.40 | -26.64 |
| Profit Margin | - | - | -19.54 | -36.15 | -27.17 |
| EBITDA | -65.27 Million | -60.89 Million | -52.08 Million | -15.95 Million | -26.01 Million |
| Earnings Before Tax Margin | - | - | -18.99 | -35.81 | -27.65 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 2.75 Million | - | - | - |
| Cost of Revenue | 255 Thousand | 248 Thousand | 227 Thousand | 822 Thousand | 478 Thousand | 449 Thousand |
| Gross Profit | -255 Thousand | -248 Thousand | 2.52 Million | -822 Thousand | -478 Thousand | -449 Thousand |
| Operating Expenses | 12.26 Million | 13.78 Million | 13.2 Million | 65.27 Million | 17.85 Million | 18.29 Million |
| Selling, General and Administrative Expenses | 6.15 Million | 6.2 Million | 5.6 Million | - | 6.63 Million | 7.2 Million |
| Research and Development Expenses | 6.11 Million | 7.58 Million | 7.6 Million | - | 11.22 Million | 11.08 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 12.52 Million | 14.03 Million | 13.43 Million | 66.09 Million | 17.85 Million | 18.29 Million |
| Operating Income | -12.52 Million | -14.03 Million | -13.43 Million | -66.09 Million | -17.85 Million | -18.29 Million |
| Interest Expense | 1.27 Million | 1.29 Million | 1.29 Million | 5.08 Million | 1.31 Million | 1.26 Million |
| Income Tax Expense | -6.55 Million | -7.29 Million | -6.95 Million | -33.91 Million | -9.13 Million | -9.36 Million |
| Earnings before Tax | -13.36 Million | -14.77 Million | -14.05 Million | -67.88 Million | -18.33 Million | -18.66 Million |
| Net Income | -6.8 Million | -7.48 Million | -7.09 Million | -33.97 Million | -9.19 Million | -9.3 Million |
| Earnings Per Share Basic | -0.26 | -0.29 | -0.27 | - | -0.36 | -0.37 |
| Earnings Per Share Diluted | -0.26 | -0.29 | -0.27 | - | -0.36 | -0.37 |
| Weighted Average Shares Outstanding | 26.32 Million | 26.03 Million | 25.87 Million | 25.5 Million | 25.55 Million | 25.34 Million |
| Weighted Average Shares Outstanding (Diluted) | 26.32 Million | 26.03 Million | 25.87 Million | 25.5 Million | 25.55 Million | 25.34 Million |
| Gross Margin | - | - | 0.92 | - | - | - |
| EBIT Margin | - | - | -4.80 | - | - | - |
| Profit Margin | - | - | -2.58 | - | - | - |
| EBITDA | -12.26 Million | -13.78 Million | -13.2 Million | - | -17.01 Million | -17.2 Million |
| Earnings Before Tax Margin | - | - | -4.89 | - | - | - |
OBDE
0064
JNNDF
PYTCF
600681
ALY